Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

F-star Therapeutics Announces First Patient Dosed in FS120 Trial

americanpharmaceuticalreviewDecember 24, 2020

Tag: FS120 , F-star Therapeutics , OX40 , CD137

PharmaSources Customer Service